Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Savara Inc. (SVRA) Financial Statements

Free cash flow over the same period: -$110.7M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SVRASavara Inc.Follow SVRA — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
867.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2006
Dec 06
FY2007
Dec 07
FY2008
Dec 08
FY2009
Dec 09
FY2010
Dec 10
FY2011
Dec 11
FY2012
Dec 12
FY2013
Dec 13
FY2014
Dec 14
FY2015
Dec 15
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross profit————0.5————————————————
Research & development—————5.88.112.919.44.38.218.537.238.835.029.027.944.378.081.486.8
Operating income—————-13.4-15.6-21.5-29.3-5.9-10.9-30.0-70.0-79.0-49.3-41.5-38.8-60.0-103.2-123.5-143.6
Pre-tax income-29.3-22.1-26.6-11.3-8.5-13.3-15.6-21.5-28.7-9.0-11.3-33.4-68.6-78.2-49.6-43.0-38.2-54.7-95.9-118.8-139.3
Income tax————————0.00.0-0.4-3.6-7.1—————0.00.0—
Net income-29.3-22.1-26.6-11.3-8.5-13.3-15.6-21.5-28.7-9.0-10.9-29.8-61.5-78.2-49.6-43.0-38.2-54.7-95.9-118.8-139.3
Diluted EPS ($)—————-0.47-0.33-0.28-0.23-9.48-5.62-1.76-1.85-1.95-0.84-0.32-0.25-0.33-0.48-0.53-0.55
Diluted shares (mn)————————————————152.8165.2198.2222.4—

USD millions · SEC XBRL

Savara Inc. — questions

What is Savara Inc.'s net income?
-$139.3M over the twelve months to 2026-06-30.
What is Savara Inc.'s free cash flow?
-$110.7M over the twelve months to 2026-06-30.
What are Savara Inc.'s diluted earnings per share?
$-0.55 over the twelve months to 2026-06-30.

Every figure on this page comes from Savara Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.